Strategic use of levofolinic acid for methotrexate-induced side effects in juvenile idiopathic arthritis: a prospective observational study

To evaluate the efficacy of levofolinic acid (LVF) administered 48 h before methotrexate (MTX) in reducing gastrointestinal side effects without interference with drug efficacy.

Source: Pediatric Rheumatology - February 15, 2023 Category: Rheumatology Authors: Giorgia Martini, Alessandra Meneghel, Michele Fastiggi, Filippo Dell ’Apa, Fabio Vittadello and Francesco Zulian Tags: Short Report Source Type: research